Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()

• 44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer; • The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively. • Metastasis at the surgical site and chronic inflammation implicated.

Detalles Bibliográficos
Autores principales: Skwara, Amanda J., Schilder, Russell J., Zibelli, Allison, Rosenblum, Norman G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862313/
https://www.ncbi.nlm.nih.gov/pubmed/24371706
http://dx.doi.org/10.1016/j.gynor.2013.06.005
Descripción
Sumario:• 44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer; • The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively. • Metastasis at the surgical site and chronic inflammation implicated.

Ejemplares similares